Introduction
Among the causes of mortality in Russia, as in most developed countries, the first position is occupied by the cardiovascular diseases (CVD) [1] . CVD have caused 50.1% cases of total mortality in 2014 in Russia [1] . In some countries with a comparable economic level, the mortality rate is lower and life expectancy is higher than that in Russia [2] . It may be caused by different reasons, including an insufficient quality of healthcare.
In various countries, there are a number of registries that include patients with main chronic CVD, such as hypertension (Htn) [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] , coronary artery disease (CAD) [9, [13] [14] [15] [16] [17] [18] , and chronic heart failure (CHF) [15, 16, [19] [20] [21] [22] [23] . The main goal of registries is to fill the gap between probative data of randomized controlled trials and real clinical practice [24] . The registries can also be the basis for epidemiologic studies, original studies, risk modeling, etc.
The registry is an ideal tool for studying the real clinical practice, especially when it is necessary to improve the quality of healthcare [25] . Registries of CVD can be useful for increasing the management efficiency in the healthcare system [25] . The problem of improving the quality control methods of providing healthcare to patients is very relevant [8, 26, 27] , including for Russia [28] . In real practice, the use of existing Russian healthcare standards is often accompanied by various difficulties, for region. Ivanovo region is a main participant which is now owned by a majority of patient data in database. Ivanovo region is a region in the Central Federal District of Russia. According to official data of Federal State Statistics Service of Russian Federation (http://www.gks.ru), the population of Ivanovo region was 1,036,900 people (44.9% male) in January 2015. It is 2.7% of population of the Central Federal District of Russia, and 0.7% of total Russian population (http://www.gks.ru). The main demographic characteristics of Ivanovo region are the following: the proportion of adult people is 84.4% (vs 82.4% in all-Russia), mean age of inhabitants is 41.5 years (vs 39.5 years in all-Russia), the proportion of urban people is 81.2% (vs 74 .0% in all-Russia), and cardiovascular mortality among total population is 0.64% (vs 0.65% in all-Russia). Now, 4.2% (36,424 people) of adult population (875,513 people) of Ivanovo region are registered in the RusR-Htn-CAD-CHF. In other regions of Russia, the using of RusR-Htn-CAD-CHF is only at the beginning.
Design of RusR-Htn-CAD-CHF
The RusR-Htn-CAD-CHF is a retrospective, continuous, nationwide, web-based registry operating online (URL: http://62.117.81.44/Register/login.aspx). The design of RusR-Htn-CAD-CHF is based on the national and international clinical guidelines on diagnostics and treatment of Htn, CAD, and CHF [36] [37] [38] [39] [40] [41] [42] .
Access to the Registry is given to registered members. Each user has a unique identification number and password to log into the database. The web forms are designed to be interactive. They limit or exclude certain options in order to avoid the entry of conflicting or spurious data. Wherever possible, the data are entered by selection from "drop-down" lists in order to minimize the number of keyboard errors. The purpose of all the abovementioned measures is to maximize the accuracy of data.
he web interface of RusR-Htn-CAD-CHF contains 9 web forms with the following titles: i) Personal data of patients; ii) Past history; iii) Results of physical examination at visit; iv) Results of instrumental examinations; v) Results of laboratory tests; vi) Non-pharmacologic treatment; vii) Drug treatment; viii) Invasive treatment; ix) Diagnosis and its codes according to the International Classification of Diseases 10 (ICD-10). Each web form can be saved unlimited number of times with different dates that allows accumulating the information about the dynamics of clinical parameters of patients over time.
Patients
The RusR-Htn-CAD-CHF enrolls patients with Htn and/or CAD and/or CHF receiving primary healthcare in Russia. The enrollment of patients started in January 2013 and is continued up to the present day.
Data collection
The health facilities participating in the RusR-Htn-CAD-CHF were asked to include all patients following inclusion criteria treated for Htn, CAD, and CHF. For each included patient, new data may be added to the database annually in the case of necessity. Thus, the RusR-Htn-CAD-CHF can be used not only for the retrospective study, but also for the prospective evaluation (observation). Several health facilities can enter data on the same patient, if they provided him medical care at the same time or sequentially. The source of patients' data is the patient medical card and/or the hospital chart. Тhe design of RusR-Htn-CAD-CHF does not allow to study of mortality in patients with chronic CVD.
In each center, one or several physicians were trained to log the data of patients into the Registry. To help these physicians, a detailed user manual was developed [44] . This user manual is available on the RusR-Htn-CAD-CHF website.
Currently, the RusR-Htn-CAD-CHF contains the data on more than 41,000 patients with one or several chronic CVD (Htn, CAD, and CHF) who were followed-up in 2013-2015. As for the proportion of chronic CVD presentations included in the Registry since 2013, we have only an approximate estimation. For example, the main participant (Ivanovo region) owns 36,424 patients in the registry. That is about 4.2% of the total number of adults in this region. In other regions, this proportion is even smaller.
The health facilities are interested in accurate data collection because these data are analyzed further by experts separately for each center and used on site for healthcare quality management.
Data security
Some of the main features of database and web security issues should be mentioned briefly. As it is mentioned above, all users are assigned a unique username/password combination that is used to log on to the RusR-Htn-CAD-CHF. In this way, all transactions are recorded automatically in the web server's log.
All the data are pseudonymously entered into a web-based database protected by a password on a safe server of the Russian Cardiology Research and Production Complex (Moscow, Russia) using SSL connections. Subject identification is possible only at the local study site and participating centers are exclusively able to review and modify the patient data. The data on patients with chronic CVD can be added to the RusR-Htn-CAD-CHF and can be changed, but cannot be removed. The transmitted data are stored in the central database on the central server at the Russian Cardiology Research and Production Complex (Moscow, Russia).
The purpose of all the above-mentioned measures is to ensure the confidentiality of data.
Ethical aspects
The study protocol including patient information and consent forms has been reviewed and approved by the Ethics Commission of the Russian Cardiology Research and Production Complex (Moscow, Russia).
All patients must give informed consent before inclusion of their personal and clinical data in the RusR-Htn-CAD-CHF. The standard informed consent form is available on the RusR-Htn-CAD-CHF website. Patients gave their informed consent during their first visit to health facilities in the period of inclusion.
Personal data are coded automatically when entered into the registry. Names, addresses and other data which allows identification of a patient do not stored on the central server.
Patients' personal data are available only for staff of a healthcare facility where patients are treated.
The appropriate measures are used to guarantee maximal data confidentiality.
Data analysis
Within the RusR-Htn-CAD-CHF, an analytical module was created for the assessment of guidelines implementation in patients with Htn, CAD, and CHF. The main aim of this analytical module is to implement the system analysis of clinical cases to achieve the clinical result (for example, to achieve the target blood pressure in patients with Htn).
In the RusR-Htn-CAD-CHF, the completeness of clinical guidelines performance in real healthcare is evaluated using the developed clinical indicators, which are calculated automatically by using the database query for a required cohort of patients (in primary care facilities, in regions of Russia, or in all-Russia). These indicators were developed on the basis of national and European guidelines using the ACCF/AHA methodology for the development of quality measures for cardiovascular technology [45] . The details of clinical indicators are presented in Appendix C.
Based on the presented clinical indicators, the quality of care in patients with chronic CVD could be compared among Russian healthcare units. This approach allows not only evaluation of the quality of care in a particular unit based on clinical guidelines, but also allows comparative evaluation of health facilities in a city, region or the whole Russia.
Discussion
Registries of diseases allow collecting data from large populations of patients. Currently, the use of RusR-Htn-CAD-CHF is local. Only one region (Ivanovo region) uses the Registry systematically. In other regions of Russia, we have only the first results of RusR-Htn-CAD-CHF using. However, these results can be employed for the evaluation of quality of healthcare in health facilities participating in the project [46] [47] [48] [49] [50] . The first results of RusR-Htn-CAD-CHF caused debate among some Russian cardiologists. Some authors reported their comments and suggestions to improving this Registry [51] . Heterogeneity of quality and efficiency of secondary prevention of CVD in different regions of Russia (according to 2014 report [47] ) shows relevant improvement of healthcare in these regions based on using the RusR-Htn-CAD-CHF [52] . According to S.V. Balashov [52] , similar approach can be used also for primary cardiovascular prevention, which is also an urgent problem for the Russian cardiology. There is evidence of the successful use of RusR-Htn-CAD-CHF for healthcare quality control in a certain clinic [53, 54] . The basic principle of clinical indicators of RusR-Htn-CAD-CHF (see Appendix C) is the following: the quality indicator must contribute to the achievement of clinical outcome.
Since the RusR-Htn-CAD-CHF uses key data elements and definitions recommended by the American College of Cardiology and American Heart Association, the results of our study have the potential to be used for cross-country comparison of different registries in other European countries and the USA.
Currently, the data filling of RusR-Htn-CAD-CHF faced some difficulties. The use of RusR-Htn-CAD-CHF in practical healthcare meets the problem of reorganizing the workload of staff in health facilities providing care for patients with chronic CVD. Untrained users may have some difficulties with the use of RusR-Htn-CAD-CHF. To solve this problem we developed a user manual [44] .
Due to the first Russian registry of Htn (2006 Htn ( -2012 , it became possible to trace for several years the level of implementation of clinical guidelines among Russian patients with Htn. It was found out that the level of guidelines implementation is low, compared to economically developed countries [34, 35, 55, 56] . In 2008, only 22% of hypertensive patients had the goal blood pressure and/or satisfactory quality of healthcare [32] . It has been shown that primary care physicians do not conduct correction of cardiovascular risk factors and diagnosis of lesions of target organs and/or associated clinical conditions, which leads to an underestimation of cardiovascular risk and inadequate choice of treatment tactics in patients with Htn [32, 34] . In 2007, 64% of hypertensive patients had medicinal purposes in medical card [34] . At the same time, assigned antihypertensive therapy is fully consistent with the clinical status in 6.5% of total patients with Htn [34] .
One of the reasons of low guidelines implementation is a set of current healthcare indicators powered by the Russian Ministry of Health. These indicators are solely organizational. They are used to calculate the average cost of treatment of a typical patient. These indices are not associated with the clinical objectives of treatment [28] . Such dissonance is a major problem in the transition of the Russian healthcare system to higher quality level. Novel registry (the RusR-Htn-CAD-CHF) will provide an objective view not only on patients with Htn, but also on patients with CAD and CHF. In the future, the RusR-Htn-CAD-CHF may provide the basis for implementing local initiatives, such as "pay for performance". Similar projects were implemented in the US and UK [57] [58] [59] .
In recent years, the attention to primary and secondary prevention of chronic CVD significantly increased in Russia and other countries [60] [61] [62] [63] [64] . Some authors have shown that coronary revascularization was often performed unnecessarily from the clinical point of view [65] . It is known that Russian patients with CAD are characterized by more severe clinical status compared with the same patients from other economically developed countries [66, 67] . However, the percitaneous coronary intervention (PCI) is carried out less frequently in these patients in Russia [66] [67] [68] . Soon, criteria of assessment of needs and appropriateness of coronary revascularization [69] will be added to analytical apparatus of the RusR-Htn-CAD-CHF. It is important for modern healthcare in Russia, taking into account the lack of probative data on the necessity and appropriateness of using the coronary revascularization in CAD patients in Russia. Our systematic search in database of Russian Science Citation Index gave no results.
The RusR-Htn-CAD-CHF may be also used as a basis for improving the quality of primary and secondary prevention of chronic CVD. Some Russian health facilities are already using the RusR-Htn-CAD-CHF for the assessment of quality of cardiovascular primary prevention [53] .
In Russia, there are other registries of patients with Htn (RECVASA registry, local registries in Tomsk region, Tyumen region, and some other regions) [70] [71] [72] , CAD (PROGNOS CHD registry and RECVASA registry) [73, 74] , and CHF (RIF-CHF registry and Russian Hospital Chronic Heart Failure Registry) [75, 76] . But the RusR-Htn-CAD-CHF is currently the largest registry of Russian patients with chronic CVD.
Currently, the RusR-Htn-CAD-CHF is focused on primary care in Russia. But in the near future, we plan to expand this registry to covering secondary care facilities.
Conclusion
The RusR-Htn-CAD-CHF is a perspective project for healthcare quality assessment in patients with Htn, CAD, and CHF, living in Russia. This registry can be used for dynamic monitoring and improving the quality of primary care (and secondary care in near future) in Russia. Additionally, the RusR-Htn-CAD-CHF can be used for different epidemiologic studies in Russian patients with Htn, CAD, and CHF. 
